Nu Skin Enterprises Q3FY26 Results: Revenue $311M, EPS $0.10
Nu Skin Enterprises reported Q3FY26 revenue of $311M and adjusted EPS of $0.10, within guidance. Full-year sales outlook lowered to $1.26B-$1.29B, below consensus. Gross margin declined to 65% from 70.5%. Q4 revenue expected at $310M-$340M, EPS at $0.11-$0.21. Company ranked No. 1 in beauty and wellness devices by Euromonitor.
How this was made
The 30-second read
Why it matters
The earnings release shows revenue within guidance but below analyst expectations, with full‑year sales outlook trimmed, likely prompting a price decline.
Market read
First‑time earnings disclosure with lowered guidance; traders should watch for price reaction and potential short‑term weakness.
What to watch
Strong growth in the PRISM wellness platform and upcoming India launch could offset near‑term revenue pressure.
Background
Nu Skin Enterprises Inc. (NYSE: NUS) is a global beauty and wellness company operating in ~50 markets, known for at‑home device systems.
Ticker impact
Nu Skin reported Q3 FY26 revenue of $311M and adjusted EPS of $0.10, with full-year guidance lowered, marking the first public disclosure of these results.
likely downside as investors price in weaker top‑line and reduced outlook
The company missed consensus revenue expectations and cut its full‑year sales range, which historically triggers sell‑offs for similar consumer‑tech stocks.
Market effects
Signals softness in the beauty and wellness device sector, potentially affecting peers with similar business models.
May weigh on Asian consumer discretionary stocks where Nu Skin has significant exposure.
Limited to niche consumer‑tech segment; broader market impact minimal.
Counterpoint
If the RISE platform continues to scale, the short‑term miss could be a buying opportunity at lower valuations.
Key entities
- ExecutiveRyan Napierski
President and CEO of Nu Skin, provided commentary on the results.
